PCR Cycle Threshold Values and COVID-19 Outcomes
NCT04651413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 934
Last updated 2022-05-18
Summary
This is a retrospective observational study. The study will use high quality, reliable data that has already been collected for the ISARIC 4C COVID-19 study in order to analyse the relation between predictor variables (laboratory polymerase chain reaction \[PCR\] cycle threshold \[Ct\] values) and outcomes for COVID-19 disease within a hospitalised population.
Conditions
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
PCR Value
Data collection and interpretation
Sponsors & Collaborators
-
University Hospitals of North Midlands NHS Trust
lead OTHER
Principal Investigators
-
Timothy Kemp · UHNM
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-24
- Primary Completion
- 2021-03-31
- Completion
- 2021-10-14
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)
NCT04355351 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers
NCT04445415 ·Status: UNKNOWN
-
Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19
NCT04534712 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19
NCT05092607 ·Status: UNKNOWN ·Phase: NA
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
NCT04322279 ·Status: TERMINATED
-
Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19
NCT04550390 ·Status: COMPLETED
-
RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population
NCT04427358 ·Status: COMPLETED
-
A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition
NCT04573634 ·Status: WITHDRAWN
-
Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection
NCT04863547 ·Status: UNKNOWN
-
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533 ·Status: COMPLETED ·Phase: NA
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department
NCT04583189 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
NCT04369066 ·Status: COMPLETED ·Phase: NA
-
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
NCT04385914 ·Status: UNKNOWN
-
COVID Infection in Pediatric Surgical Patient
NCT05898529 ·Status: RECRUITING
-
Post COVID-19 Complications in Children
NCT05745974 ·Status: UNKNOWN
-
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
NCT05244967 ·Status: RECRUITING
-
Using of Biomarkers and Blood Culture in Early Detection of Systemic Infections
NCT05737537 ·Status: UNKNOWN ·Phase: NA
-
CovidSurg-3: Outcomes of Surgery in COVID-19 Infection
NCT05161299 ·Status: UNKNOWN
-
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
NCT04397666 ·Status: UNKNOWN ·Phase: NA
-
Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers
NCT04525417 ·Status: COMPLETED ·Phase: NA
-
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720 ·Status: COMPLETED ·Phase: NA